This inventor holds 3 USPTO granted patents. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fukuoka, JP (1998 - 2000)
- Chikujo-gun, JP (2000)
Company Filing History:
Years Active: 1998-2000
Title: Innovations of Hideaki Sato in Pharmaceutical Chemistry
Introduction
Hideaki Sato is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the production of optically active compounds. With a total of 3 patents to his name, Sato's work has implications for the treatment of various medical conditions.
Latest Patents
One of Sato's latest patents is a production method for optically active imidazole compounds. This invention provides a method for producing an optically active 4-[.alpha.-hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoic acid or a pharmaceutically acceptable salt thereof. The process involves subjecting a specific compound to optical resolution by fractional crystallization, followed by a hydrolysis reaction. This method is particularly useful for the industrial large-scale production of the optically active compound, which serves as a thromboxane synthetase inhibitor and an agent for the prophylaxis and treatment of diabetic complications.
Career Highlights
Hideaki Sato is currently employed at Yoshitomi Pharmaceutical Industries, Ltd., where he continues to innovate in the field of pharmaceutical development. His work has garnered attention for its potential applications in improving health outcomes.
Collaborations
Sato has collaborated with notable colleagues such as Syuji Ehara and Kazuyuki Kawasaki. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Hideaki Sato's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has the potential to improve therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile